...
首页> 外文期刊>PLOS Neglected Tropical Diseases >Capsules, Toxins and AtxA as Virulence Factors of Emerging Bacillus cereus Biovar anthracis
【24h】

Capsules, Toxins and AtxA as Virulence Factors of Emerging Bacillus cereus Biovar anthracis

机译:胶囊,毒素和AtxA作为新兴蜡状芽孢杆菌Biovar炭疽的致病因子。

获取原文
           

摘要

Emerging B. cereus strains that cause anthrax-like disease have been isolated in Cameroon (CA strain) and C?te d’Ivoire (CI strain). These strains are unusual, because their genomic characterisation shows that they belong to the B. cereus species, although they harbour two plasmids, pBCXO1 and pBCXO2, that are highly similar to the pXO1 and pXO2 plasmids of B. anthracis that encode the toxins and the polyglutamate capsule respectively. The virulence factors implicated in the pathogenicity of these B. cereus bv anthracis strains remain to be characterised. We tested their virulence by cutaneous and intranasal delivery in mice and guinea pigs; they were as virulent as wild-type B. anthracis. Unlike as described for pXO2-cured B. anthracis, the CA strain cured of the pBCXO2 plasmid was still highly virulent, showing the existence of other virulence factors. Indeed, these strains concomitantly expressed a hyaluronic acid (HA) capsule and the B. anthracis polyglutamate (PDGA) capsule. The HA capsule was encoded by the hasACB operon on pBCXO1, and its expression was regulated by the global transcription regulator AtxA, which controls anthrax toxins and PDGA capsule in B. anthracis. Thus, the HA and PDGA capsules and toxins were co-regulated by AtxA. We explored the respective effect of the virulence factors on colonisation and dissemination of CA within its host by constructing bioluminescent mutants. Expression of the HA capsule by itself led to local multiplication and, during intranasal infection, to local dissemination to the adjacent brain tissue. Co-expression of either toxins or PDGA capsule with HA capsule enabled systemic dissemination, thus providing a clear evolutionary advantage. Protection against infection by B. cereus bv anthracis required the same vaccination formulation as that used against B. anthracis. Thus, these strains, at the frontier between B. anthracis and B. cereus, provide insight into how the monomorphic B. anthracis may have emerged.
机译:在喀麦隆(CA株)和科特迪瓦(CI株)中分离出了引起炭疽样疾病的蜡状芽孢杆菌。这些菌株是不寻常的,因为它们的基因组特征表明它们属于蜡状芽孢杆菌种,尽管它们带有两个质粒pBCXO1和pBCXO2,它们与炭疽芽孢杆菌的pXO1和pXO2质粒高度相似,可编码毒素和毒素。聚谷氨酸胶囊。涉及这些蜡状芽孢杆菌炭疽杆菌菌株的致病性的毒力因子仍有待鉴定。我们通过小鼠和豚鼠的皮肤和鼻内给药测试了它们的毒性。它们与野生型炭疽杆菌一样有毒。与针对pXO2固化的炭疽芽孢杆菌所描述的不同,经pBCXO2质粒固化的CA株仍然具有高毒力,表明存在其他毒力因子。实际上,这些菌株同时表达了透明质酸(HA)胶囊和炭疽芽孢杆菌聚谷氨酸(PDGA)胶囊。 HA胶囊由pBCXO1上的hasACB操纵子编码,其表达受全局转录调节剂AtxA调节,后者控制炭疽杆菌中的炭疽毒素和PDGA胶囊。因此,HA和PDGA胶囊和毒素由AtxA共同调节。我们通过构建生物发光突变体,探索了毒力因子对CA在其宿主内定植和传播的各自影响。 HA胶囊本身的表达导致局部增殖,并且在鼻内感染期间导致局部扩散到邻近的脑组织。毒素或PDGA胶囊与HA胶囊的共表达使系统散播成为可能,从而提供了明显的进化优势。防止蜡状芽孢杆菌对炭疽芽孢杆菌的感染需要与针对炭疽芽孢杆菌相同的疫苗接种配方。因此,这些菌株位于炭疽芽孢杆菌和蜡状芽孢杆菌之间的边界,可提供有关单形炭疽芽孢杆菌如何出现的见解。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号